AU Patent

AU2016338753B2 — Extended use zirconium silicate compositions and methods of use thereof

Assigned to ZS Pharma Inc · Expires 2019-04-18 · 7y expired

What this patent protects

The present invention relates to zirconium silicate compositions having a lead content that is below 0.6 ppm and methods of manufacturing zirconium silicate at reactor volumes exceeding 200-L with a lead content below 1.1 ppm. The lead content of the zirconium silicate of this in…

USPTO Abstract

The present invention relates to zirconium silicate compositions having a lead content that is below 0.6 ppm and methods of manufacturing zirconium silicate at reactor volumes exceeding 200-L with a lead content below 1.1 ppm. The lead content of the zirconium silicate of this invention are within the levels that are considered acceptable for extended use given the dose requirements for zirconium silicate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016338753B2
Jurisdiction
AU
Classification
—
Expires
2019-04-18
Drug substance claim
No
Drug product claim
No
Assignee
ZS Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.